Similarly, an exon-skipping strategy was evaluated in a mouse model of X-linked Alport syndrome, a rare kidney disease caused by mutations in COL4A5, and was shown to improve the collagen IV heterotrimer formation and prolong the survival of mice [33]. This evidence concerns the gene COL4A5 and Alport syndrome.